Skip to main content

‘Fraud on the Market’ and the Economics of Securities Litigation Claims in Europe

A key economic question in securities litigation is how to determine the amount of harm that can be attributed to alleged misstatements and that may be considered as damages. Securities litigation and the legal frameworks around the determination of damages have been developing in different jurisdictions in Europe over the past ten years.

This white paper provides a brief overview of the classical approach to determining damages that is prevalent in many European jurisdictions; describes the alternative framework called ‘Fraud on the Market’ that has been commonly accepted in US courts; summarizes the evolving state of legal frameworks in some of the leading European jurisdictions; and explains the economics and practicalities of calculating inflation damages.

‘Fraud on the Market’ and the Economics of Securities Litigation Claims in Europe

A key economic question in securities litigation is how to determine the amount of harm that can be attributed to alleged misstatements and that may be considered as damages. Securities litigation and the legal frameworks around the determination of damages have been developing in different jurisdictions in Europe over the past ten years.

This white paper provides a brief overview of the classical approach to determining damages that is prevalent in many European jurisdictions; describes the alternative framework called ‘Fraud on the Market’ that has been commonly accepted in US courts; summarizes the evolving state of legal frameworks in some of the leading European jurisdictions; and explains the economics and practicalities of calculating inflation damages.

Absorption Pharmaceuticals, LLC v. Reckitt Benckiser, LLC

Analysis Group was retained on behalf of Reckitt Benckiser, the defendant in a fraud and trade secret misappropriation lawsuit brought by Absorption Pharmaceuticals arising out of a failed acquisition.

En savoir plus

Absorption Pharmaceuticals, LLC v. Reckitt Benckiser, LLC

Analysis Group was retained on behalf of Reckitt Benckiser, the defendant in a fraud and trade secret misappropriation lawsuit brought by Absorption Pharmaceuticals arising out of a failed acquisition.

En savoir plus

  • $130 Million Award to Analysis Group’s Biopharmaceutical Client in Breach of Contract Ruling
    En savoir plus
  • 64th American Society of Hematology Annual Meeting and Exposition to Feature New Outcomes Research from Analysis Group
    En savoir plus
  • 2022 Forbes Survey Ranks Analysis Group Among the Most Recommended Firms for Legal and Litigation Consulting
    En savoir plus
/

  • Managing Principal Jeffrey H. Kinrich to Discuss Concepts from New Edition of Lost Profits Damages
    En savoir plus
  • Managing Principal Samuel Weglein to Discuss Challenges in Labor Cartel Cases at NYSBA Antitrust Law Section Annual Meeting
    En savoir plus
  • Vice President Kristof Zetenyi to Join Class Action Litigation Webinar
    En savoir plus
/